BioHealth News Archive

Viela Bio IPO: At Phase 3 Of Development With Positive Results – VIELA BIO, INC. (Pending:VIE) | Seeking Alpha

Viela Bio IPO: At Phase 3 Of Development With Positive Results – VIELA BIO, INC. (Pending:VIE) | Seeking Alpha

With product candidates acquired from AstraZeneca (AZN) and MedImmune, Viela Bio (VIE) is clinical-stage biotechnology to be followed carefully. Besides, at Phase 3 of…

Read More
9 health tech trends drawing venture capital

9 health tech trends drawing venture capital

Venture funding for digital health companies reached an all-time high in the first half of 2019, totaling $5.1 billion across 318 deals, according to…

Read More
QIAGEN Announces Change in Global Sales Structure | Technology Networks

QIAGEN Announces Change in Global Sales Structure | Technology Networks

QIAGEN N.V. has announced that it has decided to integrate its global sales resources into its Business Areas (Life Sciences, Molecular Diagnostics and Bioinformatics).…

Read More
New Ways of Working Together to Heal the World at Women Building Bio – Sept. 19.

New Ways of Working Together to Heal the World at Women Building Bio – Sept. 19.

Spotlights on Inspiring New Collaborative Approaches to Discovery and Development of Treatments and Cures {iframe}https://www.vabio.org/events/EventDetails.aspx?id=1239700&group=&utm_source=email&utm_medium=email&utm_campaign=Virginia%20Bio{/iframe}

Read More
Scientists discover hidden differences among cells that may help them evade drug therapy | EurekAlert! Science News

Scientists discover hidden differences among cells that may help them evade drug therapy | EurekAlert! Science News

University of Maryland researchers have discovered that seemingly identical cells can use different protein molecules to carry out the same function in an important…

Read More

Immunomic Therapeutics Appoints Harvard’s Brain Tumor Expert, Dr. E. Antonio Chiocca, to its Scientific Advisory Board – Immunomic Therapeutics

Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that it has appointed brain tumor expert E. Antonio ‘Nino’ Chiocca, M.D.,…

Read More
Save the Date: BioHealth Capital Region Investment Conference October 15 + 16

Save the Date: BioHealth Capital Region Investment Conference October 15 + 16

By invitation only: For questions email BHI@BioHealthInnovation.org Gaithersburg, MD {iframe}http://www.biohealthinnovation.org/events/icalrepeat.detail/2019/10/15/1058/-/biohealth-capital-region-investment-conference{/iframe}

Read More
Startup CXO Database

Startup CXO Database

Are you an experienced biohealth entrepreneur seeking new opportunities in the BioHealth Capital Region? BioHealth Innovation is developing a database of experienced industry personnel…

Read More
The Link Between Drug Prices and Research on the Next Generation of Cures | ITIF

The Link Between Drug Prices and Research on the Next Generation of Cures | ITIF

Congress and the Trump administration are considering proposals to reduce the price of drugs, but there is a strong causal link between current drug…

Read More
Hard to Find Small Lab Space!

Hard to Find Small Lab Space!

708 Quince Orchard Road, Gaithersburg, Maryland Three move-in ready laboratory/office modules; each approximately 1,200 RSF with communal services and amenities designed to facilitate collaboration.…

Read More
10 Takeover Targets to Watch This Fall

10 Takeover Targets to Watch This Fall

Viewed simply by dollar value, the value of mergers-and-acquisitions (M&A) activity appeared to be zooming in the first half of this year: Statistics compiled…

Read More
What if aging weren’t inevitable, but a curable disease? – MIT Technology Review

What if aging weren’t inevitable, but a curable disease? – MIT Technology Review

Each Cyclops had a single eye because, legend has it, the mythical giants traded the other one with the god Hades in return for…

Read More
2 new unicorns, over $550 million in funding, in Bay Area at end of week – Silicon Valley Business Journal

2 new unicorns, over $550 million in funding, in Bay Area at end of week – Silicon Valley Business Journal

Two more Bay Area companies hit unicorn valuations of $1 billion or more at the end of the week as part of more than…

Read More
Viela Bio Announces Publication in The Lancet of Pivotal Study Results of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder | Business Wire

Viela Bio Announces Publication in The Lancet of Pivotal Study Results of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder | Business Wire

Viela Bio today announced that peer-reviewed journal, The Lancet, has published results from its pivotal study of inebilizumab in patients with neuromyelitis optica spectrum…

Read More
PeopleOnTheMove – September 2019 – BioBuzz

PeopleOnTheMove – September 2019 – BioBuzz

There were 5 New Hires and Promotions in the #BioHealthCapitalRegion in the month of August! Check out all the #PeopleOnTheMove Here Facility Logix LLC…

Read More